367 related articles for article (PubMed ID: 10551646)
1. Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
Yamaguchi M; McSweeney PA; Kimball L; Gersuk G; Hong DS; Kwok W; Storb R; Beckham C; Deeg HJ
Transplantation; 1999 Oct; 68(8):1161-71. PubMed ID: 10551646
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.
Lee JW; Gersuk GM; Kiener PA; Beckham C; Ledbetter JA; Deeg HJ
J Immunol; 1997 Oct; 159(7):3211-9. PubMed ID: 9317119
[TBL] [Abstract][Full Text] [Related]
3. Induction of negative regulators of haematopoiesis in human bone marrow cells by HLA-DR cross-linking.
Yamaguchi M; Nadler S; Lee JW; Deeg HJ
Transpl Immunol; 1999 Sep; 7(3):159-68. PubMed ID: 10608299
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
Huss R; Beckham C; Storb R; Deeg HJ
Transplantation; 1994 Dec; 58(12):1366-71. PubMed ID: 7809930
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand.
Hong DS; Beckham C; Huss R; Lee JW; Hockenbery D; Ledbetter JA; Deeg HJ
Blood; 1995 Nov; 86(9):3341-52. PubMed ID: 7579437
[TBL] [Abstract][Full Text] [Related]
6. Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules.
Greinix HT; Storb R; Bartelmez SH
Blood; 1992 Oct; 80(8):1950-6. PubMed ID: 1382714
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR-mediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway.
Lee JW; Beckham C; Michel BR; Rosen H; Deeg HJ
Blood; 1997 Jul; 90(1):217-25. PubMed ID: 9207456
[TBL] [Abstract][Full Text] [Related]
8. Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody.
Deeg HJ; Seidel K; Yu C; Nash R; Huss R; Schuening F; Storb R
Biol Blood Marrow Transplant; 1996 May; 2(2):105-11. PubMed ID: 9118299
[TBL] [Abstract][Full Text] [Related]
9. HLA-class II antigens on hemopoietic and stromal cells in human micro long-term bone marrow cultures.
Brühl P; Mergenthaler HG; Ellwart J; Dörmer P
Exp Hematol; 1990 Feb; 18(2):103-8. PubMed ID: 2303101
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment.
Deeg HJ; Huss R
Bone Marrow Transplant; 1993 Nov; 12(5):425-30. PubMed ID: 8298551
[TBL] [Abstract][Full Text] [Related]
11. Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Greinix HT; Ladiges WC; Graham TC; Maslan S; Raff RF; Sandmaier BM; Appelbaum FR; Schuening FG; Deeg HJ; Storb R
Blood; 1991 Oct; 78(8):2131-8. PubMed ID: 1912590
[TBL] [Abstract][Full Text] [Related]
12. Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand.
Deeg HJ; Beckham C; Huss R; Myerson D; Greinix H; Appelbaum FR; Graham T; Schuening F; Storb R
Blood; 1994 Apr; 83(8):2352-9. PubMed ID: 7512846
[TBL] [Abstract][Full Text] [Related]
13. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
14. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
Bruno B; Nash RA; Wallace PM; Gass MJ; Thompson J; Storb R; McSweeney PA
Transplantation; 1999 Aug; 68(3):338-44. PubMed ID: 10459536
[TBL] [Abstract][Full Text] [Related]
15. Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
Schuening F; Storb R; Goehle S; Meyer J; Graham TC; Deeg HJ; Appelbaum FR; Sale GE; Graf L; Loughran TP
Transplantation; 1987 Nov; 44(5):607-13. PubMed ID: 3318032
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of human HLA-mismatched CD34+ cells from unrelated donors in establishing in vitro hematopoiesis in allogeneic long-term marrow cultures.
La Russa VF; Kessler SW; Henson VA; Cutting M; Polsinelli T; Knight RD; Wright DG
Exp Hematol; 1996 Nov; 24(13):1475-83. PubMed ID: 8950230
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.
Lu L; Pelus LM; Broxmeyer HE; Moore MA; Wachter M; Walker D; Platzer E
Blood; 1986 Jul; 68(1):126-33. PubMed ID: 3487351
[TBL] [Abstract][Full Text] [Related]
18. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of the canine mixed lymphocyte response by HLA-DR and DP-reactive monoclonal antibodies.
Ladiges WC; Pesando JM; Severns E; Longton G; Deeg HJ; Storb R
Transplantation; 1988 Feb; 45(2):484-8. PubMed ID: 2964111
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR restriction in suppression of hematopoiesis by T cells from allogeneic bone marrow transplants.
Vinci G; Vernant JP; Cordonnier C; Bracq C; Rochant H; Breton-Gorius J; Vainchenker W
J Immunol; 1986 May; 136(9):3225-30. PubMed ID: 2937841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
